stars 1 stars 2 stars 3

DOCRO is the leading CRO focused solely on supporting the development, validation, and commercialization of in vitro diagnostic tests. Founded in 1997, DOCRO has participated in more than 120 successful PMA, BLA, and 510(k) approvals and clearances of IVD's. DOCRO and its wholly-owned subsidiary CLIA laboratory, provide customers a broad and deep set of services - Quality Manufacturing, Laboratory, and Clinical Investigator Site Audits - Regulatory Strategy Expertise, FDA Negotiation, Clinical Trial Protocol Development, Clinical Site Recruitment, Clinical Trial Management, Statistical Planning and Analysis, Final Clinical Trial Reports, and Regulatory Submissions. DOCRO is ISO 9001 and 13485 compliant.

DOCRO, INC. Questions

The DOCRO, INC. annual revenue was $5.7 million in 2026.

1 people are employed at DOCRO, INC..

DOCRO, INC. is based in Oxford, Connecticut.

The NAICS codes for DOCRO, INC. are [621, 62].

The SIC codes for DOCRO, INC. are [80, 807, 8071].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users